Phase 2 Dry-Eye Disease Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
Dry-Eye Disease
Bausch & Lomb Incorporated423 enrolled32 locationsNCT07128628
Recruiting
Phase 2
Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).
Dry-Eye Disease
Instituto Grifols, S.A.100 enrolled10 locationsNCT07264517
Recruiting
Phase 2
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease
Dry-Eye Disease
Beijing Tongren Hospital128 enrolled2 locationsNCT04673643
Completed
Phase 2
A Trial of the Safety and Therapeutic Effects of ILYX-002 Versus Vehicle Control for Treatment of Dry-Eye Disease in Patients with Autoimmune Disease
Dry-Eye Disease
Iolyx Australia Pty Ltd.110 enrolled6 locationsACTRN12623001230640